One of the most forward-thinking aspects of the National Cancer Institute Cancer Center Program is the expectation that every cancer center have a yearly visit from an External Advisory Board (EAB).
These are not accreditation visits. They are purely advisory, which encourages the cancer center staff to be completely open and transparent about challenges and opportunities and brainstorm about how to build an ideal “fantasy cancer center.” For example, how can we support clinical cancer research when funding from the federal government only covers half the costs of government sponsored clinical trials? Or, how can you incorporate the great advances taking place in molecular diagnosis into patient care? Continue reading